featured
Overall Survival of Patients With Extensive-Stage Small Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
J. Clin. Oncol 2021 Jan 13;[EPub Ahead of Print], SV Liu, M Reck, AS Mansfield, T Mok, A Scherpereel, N Reinmuth, MC Garassino, J De Castro Carpeno, R Califano, M Nishio, F Orlandi, J Alatorre-Alexander, T Leal, Y Cheng, JS Lee, S Lam, M McCleland, Y Deng, S Phan, L HornFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.